(EMCB) WisdomTree Emerging Markets - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US97717X7848

Corporate Bonds, Derivatives

Description: EMCB WisdomTree Emerging Markets

The WisdomTree Emerging Markets Corporate Bond Fund (NASDAQ:EMCB) is an exchange-traded fund that focuses on investing in corporate debt from emerging markets. Under normal market conditions, the fund allocates at least 80% of its net assets to corporate bonds, leveraging borrowings to amplify investment exposure. The funds manager actively manages the portfolio duration, maintaining it between 2 to 10 years, to navigate various market conditions.

The funds investment strategy includes the use of derivatives, such as swaps, U.S. Treasury futures, and forward currency contracts, up to 20% of its net assets. This allows the fund to hedge against potential risks or capitalize on market opportunities. As a non-diversified fund, it may concentrate its investments in a relatively smaller number of securities, potentially increasing its risk profile.

Analyzing the funds recent performance, the last price is $65.50, showing a relatively stable trend given its proximity to the 52-week high of $65.67. The short-term and long-term moving averages (SMA20: $64.81, SMA50: $64.67, SMA200: $64.16) indicate a positive trend, as the current price remains above these averages. The Average True Range (ATR) of 1.16, or 1.77%, suggests moderate daily price volatility.

Considering the funds assets under management (AUM) stand at $71.19 million, it is essential to monitor any changes in AUM as they can impact liquidity and the funds overall stability. With the current technical and fundamental data, a potential forecast could be that the fund may continue its upward trend if it sustains its position above the moving averages and if the emerging markets corporate bond sector remains favorable. However, any significant deviation from its duration target or an increase in volatility could negatively impact the funds performance.

Forecasting the funds future performance involves analyzing both technical indicators and fundamental data. If the current price maintains its level above the SMA20 and SMA50, and given the funds investment strategy, theres a possibility that it could reach or slightly exceed its 52-week high. Conversely, a decline below the SMA50 could signal a potential downturn, potentially testing the lower end of its 52-week range. Therefore, close monitoring of both market conditions and the funds specific performance metrics is crucial for investors.

EMCB ETF Overview

Market Cap in USD 76m
Category Emerging Markets Bond
TER 0.60%
IPO / Inception 2012-03-08

EMCB ETF Ratings

Growth Rating 37.0%
Fundamental -
Dividend Rating 69.2%
Return 12m vs S&P 500 -8.47%
Analyst Rating -

EMCB Dividends

Dividend Yield 12m 5.74%
Yield on Cost 5y 6.26%
Annual Growth 5y 2.95%
Payout Consistency 94.1%
Payout Ratio %

EMCB Growth Ratios

Growth Correlation 3m 95.5%
Growth Correlation 12m 78.2%
Growth Correlation 5y 28.2%
CAGR 5y 2.24%
CAGR/Max DD 5y 0.10
Sharpe Ratio 12m 0.26
Alpha 1.52
Beta 0.011
Volatility 3.76%
Current Volume 3.2k
Average Volume 20d 3.8k
Stop Loss 64.4 (-3%)
Signal 0.83

What is the price of EMCB shares?

As of August 21, 2025, the stock is trading at USD 66.42 with a total of 3,221 shares traded.
Over the past week, the price has changed by -0.41%, over one month by +0.82%, over three months by +2.71% and over the past year by +5.84%.

Is WisdomTree Emerging Markets a good stock to buy?

Partly, yes. Based on ValueRay´s Analyses, WisdomTree Emerging Markets (NASDAQ:EMCB) is currently (August 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 36.96 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EMCB is around 65.28 USD . This means that EMCB is currently overvalued and has a potential downside of -1.72%.

Is EMCB a buy, sell or hold?

WisdomTree Emerging Markets has no consensus analysts rating.

What are the forecasts/targets for the EMCB price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 71.2 7.2%

Last update: 2025-08-05 04:36

EMCB Fundamental Data Overview

Market Cap USD = 75.8m (75.8m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.71
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 75.8m USD (75.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 75.8m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 75.8m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(75.8m)/V(0.0) * Re(6.06%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 6.06% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for EMCB ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle